Skip to content

EBITDA margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
24.2%-0.2pp
Danaher logo
DanaherDHR
29.2%-0.9pp
Azenta logo
AzentaAZTA
-18.2%-19.8pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
32.6%+4.9pp
TEC
Bio-TechneTECH
23.4%-8.3pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-7%-3.2pp

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+33.1%
Enterprise value$1.24B+38.1%
P/S12.5×+0.5×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on trailing twelve months.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's EBITDA margin?
BioLife Solutions (BLFS) reported EBITDA margin of -14.8% in Q1 2026.
How has BioLife Solutions's EBITDA margin changed year-over-year?
BioLife Solutions's EBITDA margin decreased by 630.2% year-over-year, from 2.8% to -14.8%.
What is the long-term trend for BioLife Solutions's EBITDA margin?
Over 3 years (2020 to 2025), BioLife Solutions's EBITDA margin has grown at a 22.0% compound annual growth rate (CAGR), from -8.7% to -15.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.